期刊文献+

造血干细胞移植及放化疗对卵巢功能的影响

下载PDF
导出
摘要 造血干细胞移植所致的医源性损害正逐渐被人们重视,尤其是造血干细胞移植前放化疗及造血干细胞移植后免疫功能异常对卵巢功能的损害已严重影响患者的生活质量。现就国内外相关报道作一综述。
出处 《现代妇产科进展》 CSCD 北大核心 2006年第9期706-708,共3页 Progress in Obstetrics and Gynecology
  • 相关文献

参考文献31

  • 1Schimmer AD,Quatermain M,Imrie K,et al.Ovarian function after autologous bone marrow transplantation[J].Clinical Oncology,1998,16:2359-2363
  • 2Seymour JF.Ovarian tissue cryoreservation for cancer patients:who is appropriate[J].Reprod Fertil,2001,13:81-89
  • 3Blumenfeld Z.Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxity and premature ovarian failure:the role of inhibin-A and -B as marks[J].Mol Cell Endorinol,2002,187:93-105
  • 4Couto-Silva AC,Trivin C,Thibaud E,et al.Factors affecting gonadal function after bone marrow transplantation during childhood[J].Bone Marrow Transplant,2001,17:5-11
  • 5Afify A,Shan PJ,Clavano-Harding A,et al.Growth and endocrine function in children with acute myeloid leukemia after bone marrow transplantation using busulphan/cyclophosphamide[J].Bone Marrow Transplant,2000,25:1087-1092
  • 6Sklar CH,Boulad F,Small T,et al.Endocrine complications of pediatric stem cell transplantation[J].Front Biosci,2001,6:17-22
  • 7Wikstrom AM,Hovi L,Dunkel L,et al.Restoration of ovarian function after chemotherapy for osteosarcoma[J].Arch Dis Child,2003,88:428
  • 8Petrek J A,Naughton M J,Case L D,et al.Incidence,time course,and determinants of menstrual bleeding after breast cancer treatment:a prospective study[J].Clin Oncol,2006,24:1045-1051
  • 9Falcone T,Attaran M,Bedaiwy M A,et al.Ovarian function preservation in the cancer patient[J].Fertil Steril,2004,81:243-257
  • 10Posada MN,Kolp L,Garcia JE.Fetility options for female cancer ptients:facts and fiction[J].Fertil Steril,2001,75:647-653

二级参考文献19

  • 1[1]Takizawa K, yokoo I, Shima Y, et al. Quantitative evaluation for murine oocyte toxicity following intraperitoneal treatment with chemotherapeutic agents. Acta Obst Gynec Jpn. 1989, 41: 715- 722
  • 2[2]Koyama H, Wada T, Nishizawa Y, et al. Cyclophosphamide- induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer, 1977, 39: 1403-1409
  • 3[3]Fisher B, Sherman B, Rockette H, et al.L- phenylalanine mustard (L- PAN) in the management of premenopausal patients with primary breast cancer. Cancer, 1979, 44:847-857
  • 4[4]Nasiry J, Walton C, Lindow SW, et al. Spontaneous recovery of chemotherapy- induced primary ovarian failure: implication for management.Clin Endocrinol, 1997, 46:217-219
  • 5[5]Blumenfeld Z, Nissim H. Prevention of gonadal damage during cytotoxic therapy. Ann Med. 1997, 29: 199- 206
  • 6[6]Feldman JE. Ovarian failure and cancer treatment - Incidence and interventions for the premenopausal women. Oncol Nurs Forum. 1989, 16:651
  • 7[7]Wallace WHB, Shalet SM, Crowne EC, et al. Gonadal dysfunction due to cis - platinum. Medical and Pediatric Oncology, 1989, 17: 409 - 413
  • 8[8]Gershenson DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol. 1988, 6:270-275
  • 9[9]Shiromizu K, Kawana T, Sugase M, et al. pregnancies following conservative treatment of malignant ovarian tumors. Arch Gynecol Obstet. 1987,241:57-62
  • 10Boring CL & Squires TS, Cancer stastics 1991 .CA Cancer J Clin, 1991,41(1):19-36.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部